Rocket Lab (NASDAQ:RKLB) Stock Price Up 1% – What’s Next?
by Danessa Lincoln · The Markets DailyRocket Lab Corporation (NASDAQ:RKLB – Get Free Report) shares shot up 1% during mid-day trading on Monday. The company traded as high as $52.99 and last traded at $51.36. 16,896,620 shares traded hands during mid-day trading, a decline of 27% from the average daily volume of 23,066,424 shares. The stock had previously closed at $50.84.
Rocket Lab News Summary
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Rocket Lab’s core business remains comparatively strong: most revenue now comes from space systems rather than launch services, while its backlog reportedly reached approximately $2.3 billion, up 137% year over year. The company is also benefiting from agreements involving missile-defense satellites and other government programs. Rocket Lab Just Had Another Setback. Here’s Why I’m Finally Buying the Stock Anyway
- Positive Sentiment: Wall Street analysts continue to see substantial long-term upside, with Cantor Fitzgerald maintaining an Overweight rating and a $122 price target. Investor interest was also supported by Rocket Lab’s role in a NASA Mars mission expected to study how solar wind strips the planet’s upper atmosphere. Rocket Lab Stock Drops, but Cantor Fitzgerald Sticks to $122 Price Target
- Neutral Sentiment: Rocket Lab will report third-quarter 2026 results after the market close on November 9, followed by an investor conference call. The event could provide updates on Neutron redesign costs, cash usage, backlog conversion and launch timing. Rocket Lab Announces Date of Third Quarter 2026 Financial Results
- Negative Sentiment: The Neutron delay is the dominant overhang. Rocket Lab is manufacturing a replacement forward dome for the first-stage propellant tank and redesigning parts of the propulsion system, raising execution, cost and commercialization risks. The delay also leaves Electron launches and space-systems contracts carrying more of the near-term growth burden. Rocket Lab Is Back in the Spotlight
- Negative Sentiment: Investors remain concerned about valuation and profitability: Rocket Lab recently reported a quarterly loss, has a negative net margin, and trades at a highly speculative valuation despite the large backlog. Scrutiny surrounding its pending Iridium acquisition adds another source of uncertainty.
Analyst Ratings Changes
A number of research firms have recently weighed in on RKLB. Cantor Fitzgerald reissued a “mixed” rating and set a $122.00 price target on shares of Rocket Lab in a research report on Thursday, October 15th. Raymond James Financial started coverage on shares of Rocket Lab in a research note on Friday, September 11th. They issued an “outperform” rating and a $80.00 price target for the company. KGI Securities raised shares of Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 price target on the stock in a report on Monday, July 27th. KeyCorp cut their price target on shares of Rocket Lab from $135.00 to $100.00 and set an “overweight” rating on the stock in a report on Thursday, October 15th. Finally, Craig Hallum raised their price objective on shares of Rocket Lab from $98.00 to $120.00 and gave the stock a “buy” rating in a report on Monday, June 29th. Three equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Rocket Lab currently has an average rating of “Moderate Buy” and a consensus price target of $102.05.
View Our Latest Report on RKLB
Rocket Lab Stock Performance
The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $30.46 billion, a price-to-earnings ratio of -188.51 and a beta of 2.93. The company has a 50-day moving average of $67.70 and a 200-day moving average of $84.05.
Rocket Lab (NASDAQ:RKLB – Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.02). The firm had revenue of $234.07 million for the quarter, compared to the consensus estimate of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. On average, equities research analysts forecast that Rocket Lab Corporation will post -0.20 earnings per share for the current fiscal year.
Insider Activity at Rocket Lab
In other Rocket Lab news, CFO Adam Spice sold 140,157 shares of the stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $70.82, for a total transaction of $9,925,918.74. Following the sale, the chief financial officer directly owned 1,155,967 shares of the company’s stock, valued at approximately $81,865,582.94. This represents a 10.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Agostino Ricupati sold 669 shares of the firm’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $46,582.47. Following the completion of the transaction, the chief accounting officer owned 26,863 shares in the company, valued at approximately $1,870,470.69. The trade was a 2.43% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 400,749 shares of company stock valued at $26,964,474 in the last ninety days. 8.40% of the stock is owned by insiders.
Institutional Investors Weigh In On Rocket Lab
Institutional investors have recently modified their holdings of the business. BlackRock Inc. acquired a new position in shares of Rocket Lab during the second quarter worth approximately $4,124,970,000. Bank of New York Mellon Corp acquired a new stake in Rocket Lab in the 2nd quarter valued at approximately $245,764,000. Bank of America Corp DE acquired a new stake in Rocket Lab in the 2nd quarter valued at approximately $437,280,000. Legal & General Group Plc bought a new stake in Rocket Lab during the 2nd quarter valued at $171,763,000. Finally, Tema ETFs LLC raised its stake in Rocket Lab by 65,542.6% during the 2nd quarter. Tema ETFs LLC now owns 1,622,028 shares of the rocket manufacturer’s stock valued at $164,879,000 after acquiring an additional 1,619,557 shares in the last quarter. Institutional investors own 71.78% of the company’s stock.
About Rocket Lab
Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.
Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.
Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.
Further Reading
- Five stocks we like better than Rocket Lab
- 3M’s Legal Troubles Are Fading. Is the Best Part of Its Rally Still Ahead?
- The AI Buildout Is Only 15% Complete—Here Is Where the Next Dollar Actually Goes
- Cleared For Takeoff: Boeing’s 737 MAX 10 Approval Sets Up a Major Cash Flow Recovery
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over